-
-
-
-
-
-
-
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
-
-
-
-
-
-
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Announces Completion of Acquisition of Inozyme (INZY)
-
-
-
-
-
-
-
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
-
-
-
-
-
-
-
BioMarin Announces Governance Enhancements and Value Creation Initiatives
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...)
-
-
-
-
-
-
-
Express Scripts staking out million dollar gene therapies
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

